Description
BPA CANCELLATION - PRODUCT AVAILABLE VIA MCKESSON PLASMA AND BIOLOGICS
Base award description: BPA FOR CINQAIR
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-11+$0= $0
- Mod P000012017-12-22+$0= $0
- Mod P000022018-09-28+$0= $0
- Mod P000032018-12-20+$0= $0
- Mod P000042019-09-11+$0= $0
- Mod P000052019-12-23+$0= $0
- Mod P000062020-09-14+$0= $0
- Mod P000072020-12-18+$0= $0
- Mod P000082021-09-17+$0= $0
- Mod P000092021-12-15+$0= $0
- Mod P000102022-06-29+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-11 | +$0 | $0 | BPA FOR CINQAIR |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-12-22 | +$0 | $0 | 2018 PL UPDATES |
| Mod P00002· EXERCISE AN OPTION | 2018-09-28 | +$0 | $0 | EXERCISE OPTION YEAR 1 |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-12-20 | +$0 | $0 | 2019 PUBLIC LAW PRICING UPDATES |
| Mod P00004· EXERCISE AN OPTION | 2019-09-11 | +$0 | $0 | EXERCISE THE 2ND OPTION YEAR. |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-12-23 | +$0 | $0 | 2020 PUBLIC LAW PRICING UPDATES |
| Mod P00006· EXERCISE AN OPTION | 2020-09-14 | +$0 | $0 | EXERCISE OPTION YEAR 3. |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-12-18 | +$0 | $0 | 2021 PUBLIC LAW UPDATES |
| Mod P00008· EXERCISE AN OPTION | 2021-09-17 | +$0 | $0 | 2021 PUBLIC LAW UPDATES |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-15 | +$0 | $0 | 2022 PUBLIC LAW UPDATES |
| Mod P00010· LEGAL CONTRACT CANCELLATION | 2022-06-29 | +$0 | $0 | BPA CANCELLATION - PRODUCT AVAILABLE VIA MCKESSON PLASMA AND BIOLOGICS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NEN9A34LRHJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0125 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79723D0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79722D0021 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| V797D70217 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| VA797E17C0034 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| VA797E17C0033 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797E17A0007_3600 · retrieved 2026-09-26.